Literature DB >> 15229480

Metabolic profiles of cancer cells.

Julian L Griffin1, John P Shockcor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15229480     DOI： 10.1038/nrc1390

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  216 in total

Review 1.  Application of metabolomics to prostate cancer.

Authors:  Bruce J Trock
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

Review 2.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

3.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks.

Authors:  Ophélie Fliniaux; Gwenaelle Gaillard; Antoine Lion; Dominique Cailleu; François Mesnard; Fotini Betsou
Journal:  J Biomol NMR       Date:  2011-10-02       Impact factor: 2.835

4.  Revealing the metabonomic variation of EC using ¹H-NMR spectroscopy and its association with the clinicopathological characteristics.

Authors:  Ayshamgul Hasim; Hong Ma; Batur Mamtimin; Abulizi Abudula; Madiniyet Niyaz; Li-Wei Zhang; Juret Anwer; Ilyar Sheyhidin
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

5.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

6.  Metabolic profiling for the detection of bladder cancer.

Authors:  Que N Van; Timothy D Veenstra; Haleem J Issaq
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

7.  Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

Authors:  Giovanni Blandino; Mariacristina Valerio; Mario Cioce; Federica Mori; Luca Casadei; Claudio Pulito; Andrea Sacconi; Francesca Biagioni; Giancarlo Cortese; Sergio Galanti; Cesare Manetti; Gennaro Citro; Paola Muti; Sabrina Strano
Journal:  Nat Commun       Date:  2012-05-29       Impact factor: 14.919

Review 8.  Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate.

Authors:  Ovidiu C Andronesi; Otto Rapalino; Elizabeth Gerstner; Andrew Chi; Tracy T Batchelor; Dan P Cahill; A Gregory Sorensen; Bruce R Rosen
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

9.  Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.

Authors:  Leonardo Tenori; Catherine Oakman; Patrick G Morris; Ewa Gralka; Natalie Turner; Silvia Cappadona; Monica Fornier; Cliff Hudis; Larry Norton; Claudio Luchinat; Angelo Di Leo
Journal:  Mol Oncol       Date:  2014-08-10       Impact factor: 6.603

10.  A dual sensor for real-time monitoring of glucose and oxygen.

Authors:  Liqiang Zhang; Fengyu Su; Sean Buizer; Hongguang Lu; Weimin Gao; Yanqing Tian; Deirdre Meldrum
Journal:  Biomaterials       Date:  2013-10-01       Impact factor: 12.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.